16:11 EDT Oric Pharmaceuticals (ORIC) files to sell 19.23M shares of common stock for holders
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORIC:
- Promising Potential of ORIC-944 in mCRPC Treatment Drives Buy Rating and $22 Price Target
- Court blocks Trump tariffs, Musk steps away from DOGE: Morning Buzz
- Oric Pharmaceuticals data ‘home run scenario,’ says JPMorgan
- Buy Rating for Oric Pharmaceuticals Driven by Promising ORIC-944 Study Results and Undervaluation
- Closing Bell Movers: Nvidia gains 4% on earnings, lifting other semis